Chandra Bhagat Pharma Ltd — Quarterly Results & Earnings

₹30.50

-4.77%

Profit Growth YoY-33.82%Latest quarter

Sales Growth YoY-60.64%Latest quarter

Sales CAGR 5Y-1.59%5 year compound

Profit CAGR 5Y18.03%5 year compound

📋

Quarterly Performance

YoY Profit Growth-33.82%

🔴 Significant decline

YoY Sales Growth-60.64%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

0.24%

EPS Growth 5Y

18.03%

Interest Coverage

Higher = safer debt servicing

1.60

ROE

2.41%

ROCE

6.00%

💡

Growth Analysis

Chandra Bhagat Pharma Ltd reported YoY profit growth of -33.82% and revenue growth of -60.64% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -1.59% and profits at 18.03% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Chandra Bhagat Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.